基于毒损络脉理论自拟经验方治疗甲功正常桥本甲状腺炎临床研究  

Clinical study on the treatment of Hashimoto thyroiditis with normal thyroid function with self-designed empirical prescription based on the theory of toxic damage to the complex veins

在线阅读下载全文

作  者:李永超 黎应春 王德秀 Li Yongchao;Li Yingchun;Wang Dexiu(Qiannan Hospital of Traditional Chinese Medicine,Duyun,Guizhou 558000,China)

机构地区:[1]贵州省黔南州中医医院,贵州都匀558000

出  处:《首都食品与医药》2024年第16期160-161,共2页Capital Food Medicine

基  金:贵州省中医药管理局中医药、民族医药科学技术研究课题(项目编号:QZYY-2023-150)。

摘  要:目的探讨自拟经验方治疗甲功正常桥本甲状腺炎的疗效.方法选择黔南州中医医院2023年1月-2023年12月胃肠甲乳外科门诊就诊的60例甲功正常桥本甲状腺炎患者作为研究对象,随机分为对照组和治疗组,每组30例,对照组口服硒酵母,治疗组予经验方口服,比较两组的疗效.结果治疗组TGAb和TPOAb水平均低于治疗前,且低于对照组(P<0.05),两组WBC、ALT、CREA、TSH、甲状腺体积与治疗前相比未见明显差异.结论自拟经验方治疗甲功正常桥本甲状腺炎疗效较好,安全无毒副作用.Objective To explore the therapeutic effect of self-designed empirical prescription on Hashimoto thyroiditis with normal thyroid function.Methods Sixty patients with Hashimoto thyroiditis with normal thyroid function who were treated in the outpatient department of gastrointestinal and thyromilk surgery of our hospital from January to December 2023 were selected as the study objects and randomly divided into control group and treatment group,with 30 cases in each group.The control group was given oral selenium yeast,and the treatment group was given oral treatment with empirical prescription.The efficacy of the two groups was compared.Results The levels of TGAb and TPOAb in the treatment group were lower than before treatment,and lower than those in the control group(P<0.05).There were no significant differences in WBC,ALT,CREA,TSH and thyroid volume between the two groups compared with before treatment.Conclusion The self-designed empirical prescription is effective in the treatment of Hashimoto thyroiditis with normal thyroid function,safe and non-toxic side effects.

关 键 词:毒损络脉 经验方 甲功正常桥本甲状腺炎 

分 类 号:R581[医药卫生—内分泌]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象